alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 10.2





From:Faouzi Zerrouk

To: Lindsay Semple

Sent: Tuesday, December 02, 2003 6:02 PM



Lindsay:
Further to our conversation, we hereby confirm that GMS has agreed to amend its License Agreement with GPM to provide, by way of Addendum, that the license shall cover the right to use the GMS stent patent for oncology purposes (including esophagus) as well as bilary ducts. This will be consistent with prior press releases and accordingly, GMS has decided to agree to these changes on a confirmatory basis. Consequently, these changes will not entail any supplemental consideration (whether by cash or shares) to GMS. GMS has agreed to make these changes in good faith without further consideration to err on the side of prudence and avoid any argument that prior press releases may have induced the market to believe that these rights were included. The license shall not include heart applications.
GMS wishes to state for the record that each of the technologies, whether urology or other uses or applications specified above, will require a supporting R&D program to sustain its further development and position it in a manner that will allow for regulatory approval and market entry. GMS will therefore look to the principles of the Consortium Agreement to govern the payment of consideration for any further steps which GPM may wish GMS take in the development of these technologies.
Although the license agreement shall make no mention of this, we confirm GMS's understanding that GPM has not, to date, decided to acquire GMS rights in the GMS vacuum nitinol production process or to contract GMS for R&D in this regard.
We also confirm the agreement between GPM and GMS that GMS is to receive a basic management fee of US $2,500 per month for the two present GMS management staff in Moscow. This fee covers the services of our team in Moscow, to oversee on site management of product and regulatory issues. This fee does not cover any future R&D to be performed by the GMS scientists.
Attached is an invoice for US $20,000 for unpaid GMS services from May to December 2003 inclusively. As requested by the GPM auditors, all present and future fees will be supported by a GMS corporate invoice. These fees shall as of January 2004 be billed monthly and shall be paid on a net 10 day basis.
Yours sincerely,
/s/ A. Faouzi Zerrouk,

Chairman, GMS.



Michel Coderre,

/s/ President,CEO.
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                         884,503
<SECURITIES>                                   518,752
<RECEIVABLES>                                   80,775
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,117,703
<PP&E>                                         112,765
<DEPRECIATION>                                (13,732)
<TOTAL-ASSETS>                               1,954,835
<CURRENT-LIABILITIES>                          917,942
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        11,354
<OTHER-SE>                                   4,168,051
<TOTAL-LIABILITY-AND-EQUITY>                 1,954,835
<SALES>                                        105,775
<TOTAL-REVENUES>                               105,775
<CGS>                                          625,101
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             2,399,457
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           (155,719)
<INCOME-PRETAX>                            (2,933,892)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,933,892)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,933,892)
<EPS-BASIC>                                      (0.3)
<EPS-DILUTED>                                    (0.3)


</TABLE>
#### STATE v. MOORE

No. 51 PC.

Case below: 28 N.C. App. 353.

Petition for discretionary review under G.S. 7A-31 denied 2 March 1976. Motion of Attorney General to dismiss appeal for lack of substantial constitutional question allowed 2 March 1976.
#### STATE v. WATSON

No. 213P82.

Case below: 51 N.C. App. 248.

Petition by defendant for writ of certiorari to North Carolina Court of Appeals denied 13 July 1982.
THE THIRTEENTH COURT OF APPEALS

13-13-00258-CV

NAN CANION

v.

ROBERTS, ROBERTS, ODEFEY & WITTE

On Appeal from the

24th District Court of Calhoun County, Texas

Trial Cause No. 11-10-1482

JUDGMENT

THE THIRTEENTH COURT OF APPEALS, having considered this cause on 

appeal, concludes that the judgment of the trial court should be affirmed. The Court 

orders the judgment of the trial court AFFIRMED. Costs of the appeal are adjudged 

against appellant.

We further order this decision certified below for observance.

July 3, 2014
#### STATE v. KERSH

No. 108.

Case below: 12 N.C. App. 80.

Motion of Attorney General to dismiss appeal for lack of substantial constitutional question allowed 5 October 1971.
[Federal Register Volume 72, Number 195 (Wednesday, October 10, 2007)]
[Notices]
[Pages 57592-57593]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-4984]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel, Function of Toll-Like Receptors 
Throughout Gestation.
    Date: October 29, 2007.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 57593]]

    Place: National Institutes of Health, 6100 Executive Boulevard, 
Rockville, MD 20852. (Telephone Conference Call).
    Contact Person: Gopal M. Bhatnagar, PhD, Scientific Review 
Administrator, National Institute of Child Health, and Human 
Development, National Institutes of Health, 6100 Bldg Rm 5B01, 
Rockville, MD 20852, (301) 435-6889, <a href="/cdn-cgi/l/email-protection#0d6f656c79636c6a6a4d606c646123636465236a627b"><span class="__cf_email__" data-cfemail="e6848e879288878181a68b878f8ac8888f8ec8818990">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209; 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS).

    Dated: October 3, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-4984 Filed 10-9-07; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 31.1

I, David L. Cheek, certify that:

     1) I  have  reviewed  this  quarterly  report  on  Form  10-Q  of  Keystone
Consolidated Industries, Inc.;

     2) Based on my knowledge, this report does not contain any untrue statement
of a  material  fact or omit to  state a  material  fact  necessary  to make the
statements made, in light of the circumstances  under which such statements were
made, not misleading with respect to the period covered by this report;

     3) Based on my knowledge,  the financial  statements,  and other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

     4) The  registrant's  other  certifying  officer and I are  responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:

     a)   Designed  such  disclosure  controls  and  procedures,  or caused such
          disclosure   controls  and   procedures  to  be  designed   under  our
          supervision,  to ensure  that  material  information  relating  to the
          registrant,  including its consolidated subsidiaries, is made known to
          us by others within those entities,  particularly during the period in
          which this report is being prepared;

     b)   Evaluated the  effectiveness of the registrant's  disclosure  controls
          and procedures and presented in this report our conclusions  about the
          effectiveness of the disclosure controls and procedures, as of the end
          of the period covered by this report based on such evaluation; and

     c)   Disclosed  in this  report  any  change in the  registrant's  internal
          control over financial reporting that occurred during the registrant's
          most recent fiscal quarter (the registrant's  fourth fiscal quarter in
          the case of an annual  report)  that has  materially  affected,  or is
          reasonably  likely to materially  affect,  the  registrant's  internal
          control over financial reporting; and

     5) The registrant's other certifying officer and I have disclosed, based on
our most recent evaluation of internal control over financial reporting,  to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent function):

     a)   All significant  deficiencies and material weaknesses in the design or
          operation  of internal  control  over  financial  reporting  which are
          reasonably  likely to  adversely  affect the  registrant's  ability to
          record, process, summarize and report financial information; and

     b)   Any fraud, whether or not material,  that involves management or other
          employees who have a  significant  role in the  registrant's  internal
          control over financial reporting.

Date: August 8, 2006

/s/ David L. Cheek
-------------------------------------
David L. Cheek
President and Chief Executive Officer
Exhibit 15.12







Consent of Independent
Consultant



We consent to the reference to our firm
in the form and context in which it appears in this Annual Report on Form 20-F of CNOOC Limited for the year ended December 31,
2015, herein, and to the incorporation by reference in any related Prospectus Supplements of CNOOC Limited for the registration
of debt securities and guarantees previously filed with the Securities and Exchange Commission.



McDANIEL & ASSOCIATES CONSULTANTS LTD.





|                                      |                 | 
|------------------------------------- | --------------- | 
|By:                                   | /s/ P. A. Welch | 
|Name: P. A. Welch, P. Eng.           
|Title:  President & Managing Director



McDaniel & Associates Consultants Ltd.

2200, Bow Valley Square 3,

255 - 5 Avenue S.W. Calgary, Alberta,

T2P 3G6 Canada



March 31, 2016







|2200, Bow
    Valley Square 3, 255 - 5 Avenue SW, Calgary AB  T2P 3G6 | Tel: (403)
    262-5506 | Fax: (403)
    233-2744 | www.mcdan.com
|--------------------------------------------------------------------- | ----------------------- | ----------------------- | -------------
Case 1:07-cv-03545-DAB Document 17 Filed 10/11/2007 Page 1 of 6Case 1:07-cv-03545-DAB Document 17 Filed 10/11/2007 Page 2 of 6Case 1:07-cv-03545-DAB Document 17 Filed 10/11/2007 Page 3 of 6Case 1:07-cv-03545-DAB Document 17 Filed 10/11/2007 Page 4 of 6Case 1:07-cv-03545-DAB Document 17 Filed 10/11/2007 Page 5 of 6Case 1:07-cv-03545-DAB Document 17 Filed 10/11/2007 Page 6 of 6
IN THE DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FIFTH DISTRICT

NOT FINAL UNTIL TIME EXPIRES TO

 FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

JERMAINE LAMONT WILEY,

Appellant,

v. Case No. 5D16-3115

STATE OF FLORIDA,

Appellee.

________________________________/

Opinion filed December 16, 2016

3.801 Appeal from the Circuit 

Court for Orange County,

Robert J. Egan, Judge.

Jermaine Lamont Wiley, Trenton, pro se.

No Appearance for Appellee.

PER CURIAM.

Appellant, Jermaine Wiley, appeals the summary denial of his motion for additional 

jail credit filed pursuant to Florida Rule of Criminal Procedure 3.801. Because the records 

attached to the trial court’s order do not conclusively refute Wiley’s claim, we remand for 

the trial court to either attach additional records refuting the claim or hold an evidentiary 

hearing. See Sherman v. State, 185 So. 3d 1295, 1296 (Fla. 5th DCA 2016) (holding that 

remand required where it was unclear from records attached whether defendant had 
2

completed sentence in one case but had been held in custody thereafter pending 

transport to different county for disposition of second case.). 

REVERSED and REMANDED.

TORPY, EVANDER and LAMBERT, JJ., concur.
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 1 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 2 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 3 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 4 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 5 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 6 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 7 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 8 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 9 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 10 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 11 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 12 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 13 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 14 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 15 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 16 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 17 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 18 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 19 of 20
Case 1:07-cv-03580-DLC Document 30-11 Filed 06/15/2007 Page 20 of 20
EXHIBIT 32.2



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of William Lyon Homes (the Company) on Form 10-K for the period ending December 31, 2007 as filed with the Securities
and Exchange Commission on the date hereof (the Report), I, Michael D. Grubbs, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



(1)  The Report fully complies with the requirements of section
13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



/s/    MICHAEL D. GRUBBS

---

Michael D. Grubbs

Senior Vice President, Chief Financial

Officer and Treasurer

March 7, 2008



A signed original of this written statement required by Section 906 has
been provided to William Lyon Homes and will be retained by William Lyon Homes and furnished to the Securities and Exchange Commission or its staff upon request.
UNITED STATES DISTRICT COU NpEGb!I

T)OCLlR.IE&i'r 

~~~~.....-------------------------- x 

THE 1700TBALL t\SSOCIATION PREMIER : DATE FILZD: 

LEAGUE LIMITED and BOURNE CO.. on 

behalf of themselves and ail others siniilarly 07 Civ. 3582 (LLS) 

situated, (rclatcd case no. 07 Ci\. 2103 (LLS)) 

Plaintiffs, ECF Case 

YOU-1-(!BE, INC.. YOUTUBE, LLC ant1 

GOOGLE, INC.: 

Defendants. ~~~~-~~-~-~-~.~~~----~

X 

OIII)ER TO SHOW CAUSE 

PROSKAUEK ROSE LLP BERNSTEIN LITOWITZ BERGER Sr 

GROSSMANN LLI' 

I585 Broad\\ay 1285 Avenue of the Americas 

Neu Yo1.k. NY 10036-8299 New York. NY 10019 

Phone: 212-969-3000 Phone: 212-554-1400 

FAX: 212-969-2900 Fax: 2 12-554-1444 

rli~oriii!ys for L~LILI Plc~intijfi Preii~ic'r Leng~ie and Boni.ilr 

nnd jar. rh~, Prospecrive ('loss 

Case 1:07-cv-03582-LLS Document 15 Filed 07/03/2007 Page 1 of 2
Upon the I>cclaration of Noah Siski~id Gitterman. dated July 3, 2007: and the cxhibits 

annexed 111ercto: the Joint 1)eclaration of John 1'. Cofky and Louis M. Solomon, dated July 3, 

2007. and the csliibits annexed thereto; plaintiffs' Memorandum of Law In Support Of Motion 

For Appointment Of Interim Class Counsel P~lrsuant To Fcd. R. Civ. P. 23(g)(2)(a); and all prior 

PI-oceedings had hrrcin. and good cause appearing therefore, it is llereby: 

ORDERED, tliat defendants YOIITLI~C. IIIC.. YouTuhe, LLC. and Google, Inc.. and other 

/. 00 

i/ ~nterestsil parties. slio\v cause bcfure the Ilonorable Judge I.ouis L. Stanton at&-*rn. on the (. bs 

L' oSJuly 2007, in coi11-troom 21C ill tile United Stales Court Hoase. 500 I'earl Street. New LL S 

York. Neu York. wh!. the Court should not enter an Order approving the schedule requested in 

the letter subm~tted b> plaintiffs to the IIonurable Judge Louis L. Stanton on June 29, 2007, 

wliicl~ requested leave to lile a motion to designate Proskauer Rose LLP and Bcrnstein Litowitz 

l3erger & Grossmann LLP as Interim Class Counscl pursuant tu Fed. R. Civ. I-'. 23(g)(2)(A), and 

10 ser\e our papel, immediately on receipt of approval to file by thc Court; that any op~osil~g 

papers be served within one week thereafter; tliat any reply be served \\.ithin one week after that: 

;111ii tliat argument take place promptly thereafter 

ORDFIZED, th:~: service via electronic mail ofthis Ordcr to Show Cause, togct11t.r \vitli a 

copy of the papers upon which it is based (alread). served by electronic means), upon an officer 

or attorlie) for defend;uits YouTubc. Inc . YouTube. L.LC, atid Google, Inc., and upon an office1 

or attorney for the plaintiff in ihe action titled C'nl IVG1/o./ait1n1er7l LLC 1). YuuTuhe, et trl. 

3:07-cv-00617 (b1.D. Tenn.), on July 3. 2007, be dccmed sufficient service thereof. 

/. Dated Neii i.ork. Nes Yorli 

Jul,~, 2007 

SO ORDERED: 

-- 

IIONOIL4BLE I>OUIS L. STANTON, U.S.D.J. 

71 3/67 

P 

? -

Case 1:07-cv-03582-LLS Document 15 Filed 07/03/2007 Page 2 of 2
Exhibit 32
 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18, UNITED STATES CODE, SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  (1)
    
    The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and(2)
    
    The information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
 By:
    /s/ John B. Gerlach, Jr.John B. Gerlach, Jr.Chief Executive OfficerMay 12, 2008By:
    /s/ John L. BoylanJohn L. BoylanChief Financial OfficerMay 12, 2008 30
EXHIBIT 99.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Kathleen R. McElwee,  certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant  to  Section  906 of the  Sarbanes-Oxley  Act of 2002,  that the Annual
Report of VA  Software  Corporation  on Form 10-K for the fiscal year ended July
27, 2002 fully complies with the  requirements  of Section 13(a) or 15(d) of the
Securities  Exchange Act of 1934 and that  information  contained in such Annual
Report on Form 10-K  fairly  presents in all  material  respects  the  financial
condition and results of operations of VA Software Corporation.

                                             By: /s/ KATHLEEN R. MCELWEE
                                                 -------------------------------
                                           Name: Kathleen R. McElwee
                                          Title: Chief Financial Officer

                                       71
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Initial Review Group, Subcommittee D—Clinical Studies.                    

*Date:*                         December 13-14, 2005.                    

*Time:*                         9 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Marriott Bethesda North Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.                    

*Contact Person:*                         William D. Merritt, PhD, Scientific Review Administrator, Research Programs Review Branch, National Cancer Institute, Division of Extramural Activities, 6116 Executive Blvd., 8th Floor, Bethesda, MD 20892-8328, 301-496-9767,                         *wm63f@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 39.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: November 8, 2005.

Anna Snouffer,

Acting Director, Office of Federal Advisory Committee Policy.

[FR Doc. 05-23193 Filed 11-22-05; 8:45 am]

BILLING CODE 4140-01-M